Relic Tech Q1 FY27: Standalone profit up, consolidated loss narrows
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.9 pts less than Nifty Microcap 250 and 11.8 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone Q1 FY27: Total income 64.15 lakh vs 22.92 lakh year ago. Net profit 21.47 lakh vs 9.84 lakh, more than doubled. EPS Rs 0.38. Revenue from operations of 21.15 lakh is new, from trading in pharma, wellness, healthcare and chemicals. Consolidated revenue 35.49 lakh but net loss 102.75 lakh vs 368.32 lakh loss year ago, due to subsidiary losses. Subsidiaries Relic Pharma and Truhealthy Wellness lost 124.22 lakh combined. Clean auditor review.
Standalone turnaround from interest-only income to active trading. But subsidiaries still loss-making, dragging consolidated results. Watch subsidiary performance.